A water-soluble racetam nootropic studied for memory and attention, prescribed in some countries but not approved in the US.
Oxiracetam is a water-soluble member of the racetam family, structurally a hydroxylated relative of piracetam. It has been studied primarily for memory, attention, and cognitive symptoms associated with aging and certain neurological conditions. Like other racetams, it is widely used off-label as a nootropic supplement.
Its mechanism is not fully defined, but oxiracetam is generally thought to act on excitatory neurotransmission and on the cholinergic system, which is central to learning and memory. Research has pointed to effects on glutamate-related signaling and on choline-dependent pathways, which together are proposed to support synaptic communication. Some reports also describe stimulant-like alertness compared with other racetams.
On the evidence side, oxiracetam has been marketed and prescribed in some countries, and older clinical studies in cognitive impairment exist, but the overall trial quality is mixed and many studies are dated. In the United States it is neither approved nor regulated as a medicine, and it is sold as a research chemical, meaning consumers cannot assume pharmaceutical-grade quality or established safety.
Searching the published record…
Searching the published record…
Searching the published record…
Studies are surfaced live from the U.S. National Library of Medicine (PubMed). biohackr indexes and links the published record; it does not host or alter source articles.